Loading organizations...
Enko Chem develops novel, sustainable crop protection products for farmers. Its ENKOMPASS™ platform integrates DNA-encoded libraries, artificial intelligence, machine learning, and structure-based design. This data-driven approach efficiently streamlines discovery and selection of targeted, effective agrochemical solutions, addressing pests and diseases more effectively than traditional R&D.
Jacqueline Heard founded the company in 2017, leveraging her experience in chemical product innovation. Her core insight adapted proven drug discovery and development methodologies from pharmaceuticals directly to agricultural science. This strategic transfer promises efficient, environmentally conscious crop protection solutions.
Enko Chem’s innovations serve global farmers, providing tools to safeguard harvests sustainably. The company's vision centers on enabling farmers to responsibly provide food while minimizing ecological impact. They aim to establish new safety and environmental stewardship benchmarks in agriculture, fostering growth aligned with planetary health.
Enko Chem has raised $195.0M across 3 funding rounds.
Enko Chem has raised $195.0M in total across 3 funding rounds.
Enko Chem has raised $195.0M in total across 3 funding rounds.
Enko Chem's investors include Akroyd, Prem Pavoor, Endeavor8, Nufarm, Greg Hunt, Tahir Gozel, Alumni Ventures, Anterra Capital, Bill & Melinda Gates Foundation, Eight Roads Ventures, Finistere Ventures, Germin8 Ventures.
Enko Chem is an AI-informed agricultural life sciences company that develops novel, safe, and sustainable crop protection products using its proprietary ENKOMPASS™ platform, which combines DNA-encoded libraries (DEL), artificial intelligence (AI), machine learning, and structure-based design to discover targeted solutions against pests, weeds, and diseases.[1][2][3][4] It serves farmers worldwide, particularly addressing challenges like pest resistance—where 40% of crops are lost annually—and climate-driven threats, by creating potent, selective molecules faster and at lower cost than traditional methods, with potential for billions in sales across 50 programs and a first product launch by decade's end.[1][2] Backed by partners like the Gates Foundation (Series B, 2020) and collaborators such as Syngenta, Enko accelerates innovation for smallholder farmers in Sub-Saharan Africa and South Asia while scaling to global markets.[6][8]
Enko Chem emerged from the vision of applying pharmaceutical drug discovery techniques—like DEL and AI—to agriculture, led by Jacqueline Heard, CEO and co-founder, a proven scientist tackling crop threats, alongside Tom Meade, Chief Science Officer, who drives the target-based platform integrating DNA, chemistry, and machine learning.[2][7] The company, headquartered in Mystic, Connecticut, with research facilities, was founded to address stagnant innovation in crop protection, where decades-old products fail due to resistance; a pivotal moment came in September 2024 when ENKOMPASS™ identified a novel weed control mode of action (MOA) and inhibitors in just four months.[2] Early traction includes Gates Foundation investment in 2020 for affordable solutions in developing regions and partnerships like Syngenta for AI-driven weed control molecules, building on proprietary datasets from billions of binding observations.[6][8]
Enko rides the agri-tech convergence of AI, biotech, and pharma tools, adapting DEL (first in ag from pharma) to combat rising pest resistance, climate impacts, and food security needs for a growing global population.[1][2][3][5] Timing is critical amid crop losses (40% to pests) and regulatory pressures for sustainable alternatives, where Enko's platform outpaces legacy methods by unlocking novel MOAs and vast chemical spaces.[2][7] Market forces like partnerships (Syngenta, Gates) amplify reach, influencing the ecosystem by accelerating R&D—e.g., AI for weed control—and enabling affordable tools for smallholders, potentially disrupting a stagnant industry toward precision, eco-friendly crop health.[6][8]
Enko is poised to launch its first transformative product by 2030, scaling 50 programs with partners to deliver billions in revenue through safer herbicides, insecticides, and yield enhancers.[1] Trends like AI-driven drug/ag discovery, climate-resilient farming, and resistance management will propel growth, evolving Enko's influence from pioneer platform to ecosystem leader supplying novel MOAs globally. This positions Enko Chem as the force changing how the world grows food—faster, safer, and sustainably.
Enko Chem has raised $195.0M across 3 funding rounds. Most recently, it raised $80.0M Enko Chem, Inc. - Series C in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 31, 2023 | $80.0M Enko Chem, Inc. - Series C | Akroyd, Prem Pavoor, Endeavor8, Nufarm | |
| Jul 27, 2022 | $70.0M Enko Chem, Inc. - Series C | Greg Hunt | Tahir Gozel, Alumni Ventures, Anterra Capital, Bill & Melinda Gates Foundation, Eight Roads Ventures, Endeavor8, Finistere Ventures, Germin8 Ventures, Novalis LifeSciences, Rabo Food & Agri Innovation Fund, TO Ventures Food |
| Jun 26, 2020 | $45.0M Enko Chem, Inc. - Series B | Vipula Shukla |